Eleven Biotherapeutics Inc (NASDAQ:EBIO)

0.9269
Delayed Data
As of Feb 20
 +0.0018 / +0.19%
Today’s Change
0.62
Today|||52-Week Range
2.54
+14.29%
Year-to-Date
No recent news for Eleven Biotherapeutics Inc.

Today’s Trading

Previous close0.93
Today’s open0.95
Day’s range0.92 - 0.95
Volume158,947
Average volume (3 months)1,186,850
Market cap$29.4M
Data as of 3:47pm ET, 02/20/2018

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-2,155.56%
Earnings growth (next 5 years)+30.00%
Revenue growth (last year)+2,928.38%
P/E ratioNM
Price/Sales1.38
Price/Book0.59

Competitors

 Today’s
change
Today’s
% change
VICLVical Inc+0.02+1.36%
NVUSNovus Therapeutics I...+0.29+8.43%
RCKTRocket Pharmaceutica...-0.37-2.15%
JAGXJaguar Health Inc-0.01-4.00%
Data as of 4:00pm ET, 02/20/2018

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$30.0M
Annual profit (last year)$1.9M
Net profit margin6.31%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Stephen Allen Hurly
Chief Financial Officer
Richard F. Fitzgerald
Corporate headquarters
Cambridge, Massachusetts

Forecasts